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Abstract
Considering the growing recognition of the importance of patient engagement in healthcare decisions, research 
and delivery systems, it is important to ensure high quality and efficient patient engagement evaluation tools. In 
this commentary, we will first highlight the definition and importance of patient engagement. Then we discuss 
the psychometric properties of the patient engagement evaluation tools identified in a recent review on patient 
engagement in healthcare organization- and system-level decision-making. Lastly, we suggest future directions 
for patient engagement and its evaluation tools.
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Introduction 
Patient engagement in healthcare decisions, healthcare 
services organizations, health policy development, and in 
health research has been highlighted in many studies1-3 
including by patients themselves.4 Patient engagement can 
lead to better health outcomes,5 improves quality of care 
and patient safety,6 and helps control health care costs.7 The 
spectrum of patient engagement varies from simply giving 
them the information (or documentation) to partnership with 
them by involving them as equal members of the treatment 
team or of quality improvement activities.1,2 
Patients’ roles can range from relatively passive to active. 
In research, for example, active patients and the public 
engagement refers to all stages of the research process 
including “prioritization of studies; design and management 
of studies; data collection and analysis; and dissemination of 
findings.”8 Active partnership among patients, families, their 
representatives, citizens, health professionals, researchers 
and decision-makers can improve the responsiveness of the 
healthcare system to the needs of its users.1 
However, in spite of efforts to expand patient engagement, 
formal evaluations of their engagement are rare.9 Various 
frameworks are available for evaluating patient engagement 
at different levels—local, national, and international.10,11 
For instance, in Canada, the Canadian Institutes for Health 
Research’s Supporting Patient-Oriented Research (SPOR) 
program designed a patient engagement framework in 2014 
in collaboration with patient representatives and patient 
engagement experts at the SPOR patient engagement 
consultation workshop. This framework was designed to 
establish key concepts, principles and areas for patient 
engagement.10 However, there is still a knowledge gap about 
tools for evaluating patient engagement, and about the quality 
of those tools that have been identified.
Evaluation Tools 
There are a number of evaluation frameworks for patients, 
public, consumers, and community engagement at different 
levels. A recent systematic review by Dukhanian and 
colleagues12 followed a rigorous search strategy to review 
metrics and evaluation tools for patient engagement in 
decision making. Their review included the gray literature, 
with searches restricted to clinical healthcare delivery 
organizations and systems. They inductively developed a 
comprehensive taxonomy of 116 possible evaluation metrics 
and mapped 23 identified tools for measuring engagement 
of patients, the public, consumers, and communities into 
either outcome or process metrics. We used this review as a 
launchpad to further evaluate the psychometric properties 
of the identified tools, and as the authors themselves pointed 
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out, the psychometric reporting was poor. 
The review found 21 studies reporting on 23 tools. We 
used the COSMIN checklist13 to evaluate the process of 
development and/or validation of these tools. Six out of the 
21 studies had the objective of developing a tool14-19 and 
one had the objective of validating a tool (responsiveness 
parameter).20 These studies identified relatively few 
measurement properties. Good measurement properties for 
tools should include structural validity, internal consistency, 
reliability, measurement error, criterion validity, hypotheses 
testing for construct validity, measurement validity, and 
responsiveness.21-23 The original studies on the development 
and/or validation of patient engagement tools did not report 
enough information on measurement properties. Even the 
one study for which validating a tool was a stated objective 
reported only one measurement property,20 and only one out 
of the six studies whose stated objective was to develop a tool 
reported a measurement property.16 Among the other studies 
(ie, those without stated validation or development objectives), 
four reported at least one measurement property.24-27 
Discussion and Future Research in Patient Engagement
There is growing attention to patient engagement in the design 
and implementation of healthcare services and in decision 
making. However, still more effort is required to both engage 
patients and to evaluate this engagement. Here we summarize 
three suggestions for future studies in patient engagement.
First, both the systematic review by Dukhanian and 
colleagues and our evaluation of the psychometric properties 
of the tools it identified confirm the lack of studies on tool 
development and/or on validation process that use rigorous 
methods as well as a lack of detailed reporting of each step. A 
systematic review by Boivin and colleagues also suggested the 
scientific rigour of such tools in research and health system 
decision making should be improved.28 For future studies, we 
suggest that the tool development and validation process, at 
any level, follow rigorous methods and report each step in 
detail. The aim of the tool should be clearly stated in future 
studies. As suggested in a methodological article on tools in 
health or social sciences,29 three aims for patient engagement 
evaluation tools can be distinguished: (i) to discriminate 
between levels of patient engagement; (ii) to predict the results 
of research that engages patients; and (iii) to evaluate the 
change in patient engagement over time. To be rigorous, some 
psychometric properties (eg, internal consistency, temporal 
stability) should be considered for all tools regardless of 
their aims, while others are specific to the defined aim.30 For 
example, responsiveness is a validation parameter important 
for tools aiming to evaluate a change over time.30,31 
Second, the taxonomy of possible engagement evaluation 
metrics developed by Dukhanian and colleagues could be 
validated with international experts, including with patient-
evaluators and public representatives, using group-based 
approaches such as a Delphi-type exercise32 to produce a 
consensually agreed structured taxonomy. This method 
permits stakeholders to give their opinions about the 
formulation and relevance of different concepts as well as 
their definitions.
Third, as mentioned earlier, the purpose of evaluation tools 
can be to evaluate the change in patient engagement over 
time. Current fast-growing technologies such as artificial 
intelligence (AI) may facilitate achieving this goal in the 
future. AI could be used to evaluate patient engagement 
over time, based on the systematically collected data, or even 
foster patient engagement using patient records or databases 
on successful patient engagement interventions to predict 
facilitating factors for active patient engagement in a targeted 
population. 
It is important that patients be involved in the design and 
implementation of such technologies making sure their 
preferences and needs are considered.33 This will raise the 
need for development and validation of evaluation tools for 
patient engagement in AI-related research in health. More 
investigation is required into how to use AI efficiently and 
meaningfully in engaging patients and into evaluating their 
engagement at different levels.
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